Skip to main content
Medical information Clinical review pending

Genetic Testing

5 Fluorouracil 5FU Toxicity Test

The 5 Fluorouracil (5FU) Toxicity Test helps assess how your body processes the chemotherapy drug 5FU. It looks at the DPYD gene to identify potential risks of severe side effects, allowing doctors to adjust treatment plans for safer and more effective cancer care.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
4 mL (2 mL minimum) whole blood collected in a Lavender Top (EDTA) tube.
Results
Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required for this blood test. However, please ensure you have a duly filled Genomics Clinical Information Requisition Form (Form 20) available.
Test priceKSh 20,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the 5 Fluorouracil 5FU Toxicity Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Patients starting or currently receiving fluorouracil (5FU) chemotherapy.
  • ✓Individuals with a history of severe adverse reactions to 5FU.
  • ✓Patients with a family history of 5FU toxicity.
  • ✓Individuals experiencing symptoms potentially related to 5FU toxicity during treatment (e.g., severe diarrhoea, mucositis, myelosuppression).
  • ✓Patients being considered for 5FU-based chemotherapy regimens.
02

In plain language

What this test helps you understand

This test helps predict the risk of severe toxicity associated with fluorouracil (5FU) chemotherapy by analysing the DPYD gene. It aids oncologists in personalising treatment plans, potentially adjusting dosages or selecting alternative therapies to improve patient safety and treatment outcomes.
The 5 Fluorouracil (5FU) Toxicity Test is a genetic test used to understand how your body metabolises the chemotherapy drug fluorouracil (5FU). This information is crucial for patients undergoing cancer treatment with 5FU, as it helps predict the risk of severe toxicity or side effects.

This test specifically examines variations in the DPYD gene. This gene provides instructions for making an enzyme that breaks down 5FU. Certain variations in the DPYD gene can lead to reduced enzyme activity, causing 5FU to build up in the body and potentially leading to serious adverse reactions.

Understanding your DPYD gene status can help your oncologist make informed decisions about your 5FU treatment, such as adjusting the dosage or choosing alternative therapies. This personalised approach aims to maximise the benefits of chemotherapy while minimising the risk of harmful side effects.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required for this blood test. However, please ensure you have a duly filled Genomics Clinical Information Requisition Form (Form 20) available.
Sample4 mL (2 mL minimum) whole blood collected in a Lavender Top (EDTA) tube.
MethodologyGenetic analysis of the DPYD gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test identifies specific variations in the DPYD gene associated with 5FU toxicity. However, other genetic and non-genetic factors can also influence drug metabolism and toxicity risk. The test does not guarantee the absence of side effects. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

5 Fluorouracil (5FU) is a chemotherapy drug commonly used to treat various types of cancer, including colorectal, breast, stomach, and pancreatic cancer.
This test helps identify individuals who may be at higher risk of experiencing severe side effects from 5FU chemotherapy due to variations in their DPYD gene. This allows doctors to adjust treatment for better safety.
The DPYD gene provides instructions for making an enzyme that helps break down 5FU in the body. Variations in this gene can affect how quickly the drug is processed.
If you have certain variations, your doctor may adjust your 5FU dosage or consider alternative treatments to reduce the risk of severe side effects. Your doctor will discuss the results with you.
A simple blood draw is required for this test. The sample needs to be collected in a specific type of tube (Lavender Top/EDTA).
DNA Labs Kenya has branches in major cities like Nairobi, Mombasa, Kisumu, and Nakuru. We also offer home sample collection services. Please contact us to book.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp